Ampal-American Israel Corporation (Nasdaq: AMPL), a holding company in the business of acquiring and managing interests in various businesses, announced today that its Board has approved an increase in its previously announced repurchase program of Ampal's Series A, Series B and Series C debentures, which are traded on the Tel Aviv Stock Exchange ("TASE") (the "Debentures").

Under the program, Ampal is now authorized to repurchase the Debentures up to a total amount, in New Israeli Shekel, equivalent to $30 million, which is an increase of $20 million in the existing program. The repurchases may be made in transactions in TASE and outside TASE, in block trades or otherwise. The program may be suspended or discontinued at any time.

The repurchase program will be funded using Ampal’s available cash and by possible future borrowings.

About Ampal:

Ampal and its subsidiaries acquire interests primarily in businesses located in the State of Israel or that are Israel-related. Ampal is seeking opportunistic situations in a variety of industries, with a focus on energy, chemicals and related sectors. Ampal’s goal is to develop or acquire majority interests in businesses that are profitable and generate significant free cash flow that Ampal can control. For more information about Ampal please visit our web site at www.ampal.com.

Safe Harbor Statement

Certain information in this press release includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) and information relating to Ampal that are based on the beliefs of management of Ampal as well as assumptions made by and information currently available to the management of Ampal. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "intend," "plan," and similar expressions as they relate to Ampal or Ampal's management, identify forward-looking statements. Such statements reflect the current views of Ampal with respect to future events or future financial performance of Ampal, the outcome of which is subject to certain risks and other factors which could cause actual results to differ materially from those anticipated by the forward-looking statements, including among others, the economic and political conditions in Israel, the Middle East, including the situation in Iraq and Egypt, and the global business and economic conditions in the different sectors and markets where Ampal's portfolio companies operate. Should any of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results or outcome may vary from those described herein as anticipated, believed, estimated, expected, intended or planned. Subsequent written and oral forward-looking statements attributable to Ampal or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. Please refer to the Ampal's annual, quarterly and periodic reports on file with the SEC for a more detailed discussion of these and other risks that could cause results to differ materially. Ampal assumes no obligation to update or revise any forward-looking statements.

If you liked this article you might like

Israeli Stock Market Wary of Egypt Crisis

ExpressJet, Entremed: Midday Volume Plays

ExpressJet, Entremed: Midday Volume Plays

Wednesday's Winners and Losers: Ultralife Batteries

Wednesday's Winners and Losers: Ultralife Batteries

Cheapest U.S.-Traded Israeli Stocks

Cheapest U.S.-Traded Israeli Stocks

The Daily Blog Watch

The Daily Blog Watch